These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 15086040)
1. Transient ischemic attacks: Part II. Treatment. Solenski NJ Am Fam Physician; 2004 Apr; 69(7):1681-8. PubMed ID: 15086040 [TBL] [Abstract][Full Text] [Related]
2. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke. Weber R; Weimar C; Diener HC Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342 [TBL] [Abstract][Full Text] [Related]
3. Evolving perspectives on clopidogrel in the treatment of ischemic stroke. Gorelick P; Sechenova O; Hennekens CH J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):245-8. PubMed ID: 17220470 [TBL] [Abstract][Full Text] [Related]
4. Stroke subtypes and interventional studies for transient ischemic attack. Lavallée P; Amarenco P Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562 [TBL] [Abstract][Full Text] [Related]
5. Antiplatelet agents and randomized trials. Diener HC Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669 [TBL] [Abstract][Full Text] [Related]
6. Clinical inquiries. What is the best management for patients who have a TIA while on aspirin therapy? Ahmed N; Coffey JB; Oh R J Fam Pract; 2006 Jul; 55(7):627-8. PubMed ID: 16822451 [TBL] [Abstract][Full Text] [Related]
7. Cardioembolic stroke: call for a multidisciplinary approach. Babarro EG; Rego AR; González-Juanatey JR Cerebrovasc Dis; 2009; 27 Suppl 1():82-7. PubMed ID: 19342836 [TBL] [Abstract][Full Text] [Related]
8. MATCH results: implications for the internist. Lutsep HL Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967 [TBL] [Abstract][Full Text] [Related]
9. Transient ischemic attack: risk stratification and treatment. Cucchiara B; Ross M Ann Emerg Med; 2008 Aug; 52(2):S27-39. PubMed ID: 18655916 [TBL] [Abstract][Full Text] [Related]
10. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [TBL] [Abstract][Full Text] [Related]
12. Transient ischemic attack: Part II. Risk factor modification and treatment. Simmons BB; Gadegbeku AB; Cirignano B Am Fam Physician; 2012 Sep; 86(6):527-32. PubMed ID: 23062044 [TBL] [Abstract][Full Text] [Related]
13. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL; Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169 [TBL] [Abstract][Full Text] [Related]
14. [Drug therapy after stroke should be evidence-based. Organizational, economic and ethical decisions direct the choice of treatment]. Terént A Lakartidningen; 2003 Nov; 100(47):3860-4, 3866. PubMed ID: 14719239 [TBL] [Abstract][Full Text] [Related]
18. [Anticoagulation therapy in paroxysmal atrial fibrillation]. Risøe C; Gjesdal K Tidsskr Nor Laegeforen; 2004 Apr; 124(7):950-2. PubMed ID: 15060644 [TBL] [Abstract][Full Text] [Related]
19. A benefit-risk assessment of agents used in the secondary prevention of stroke. MacWalter RS; Shirley CP Drug Saf; 2002; 25(13):943-63. PubMed ID: 12381215 [TBL] [Abstract][Full Text] [Related]
20. [Drug therapy in secondary prophylaxis after transient cerebral ischemia or cerebral infarction]. Salvesen R Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2875-7. PubMed ID: 14600713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]